Omnicell earnings were $39.1M for the trailing 12 months ending Jun 30, 2026, with 70% growth year over year. The latest OMCL earnings report on Jun 30, 2026 announced Q2 2026 earnings of $24.3M, up 113.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OMCL reported annual earnings of $2.1M, with -83.6% growth.
OMCL past earnings growth
How has OMCL's earnings growth performed historically?
On OMCL's earnings call on Jul 30, 2026, Omnicell (NASDAQ: OMCL) reported Q2 2026 earnings per share (EPS) of $0.53, up 341.67% year over year. Total OMCL earnings for the quarter were $24.29 million. In the same quarter last year, Omnicell's earnings per share (EPS) was $0.12.
As of the last Omnicell earnings report, Omnicell is currently profitable. Omnicell's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $39.08 million, a 69.28% increase year over year.
What was OMCL's earnings growth in the past year?
As of Omnicell's earnings date in Jul 30, 2026, Omnicell's earnings has grown 70% year over year. This is 6.21 percentage points higher than the US Health Information Services industry earnings growth rate of 63.79%. OMCL earnings in the past year totalled $39.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.